已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension

依那普利 医学 冲程(发动机) 心肌梗塞 质量调整寿命年 内科学 成本效益 外科 血管紧张素转换酶 血压 机械工程 风险分析(工程) 工程类
作者
Tiantian Zhang,Zhuoru Liang,Tengfei Lin,David J. Cohen,Alejandro Arrieta,Xiaobin Wang,Xianhui Qin,Yuanyuan Zhang,Yong Huo,Gordon G. Liu,Jie Jiang,Zugui Zhang
出处
期刊:BMC Medicine [BioMed Central]
卷期号:20 (1) 被引量:1
标识
DOI:10.1186/s12916-022-02601-z
摘要

For hypertensive patients without a history of stroke or myocardial infarction (MI), the China Stroke Primary Prevention Trial (CSPPT) demonstrated that treatment with enalapril-folic acid reduced the risk of primary stroke compared with enalapril alone. Whether folic acid therapy is an affordable and beneficial treatment strategy for the primary prevention of stroke in hypertensive patients from the Chinese healthcare sector perspective has not been thoroughly explored.We performed a cost-effectiveness analysis alongside the CSPPT, which randomized 20,702 hypertensive patients. A patient-level microsimulation model based on the 4.5-year period of in-trial data was used to estimate costs, life years, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICERs) for enalapril-folic acid vs. enalapril over a lifetime horizon from the payer perspective.During the in-trial follow-up period, patients receiving enalapril-folic acid gained an average of 0.016 QALYs related primarily to reductions in stroke, and the incremental cost was $706.03 (4553.92 RMB). Over a lifetime horizon, enalapril-folic acid treatment was projected to increase quality-adjusted life years by 0.06 QALYs or 0.03 life-year relative to enalapril alone at an incremental cost of $1633.84 (10,538.27 RMB), resulting in an ICER for enalapril-folic acid compared with enalapril alone of $26,066.13 (168,126.54 RMB) per QALY gained and $61,770.73 (398,421.21 RMB) per life-year gained, respectively. A probabilistic sensitivity analysis demonstrated that enalapril-folic acid compared with enalapril would be economically attractive in 74.5% of simulations at a threshold of $37,663 (242,9281 RMB) per QALY (3x current Chinese per capita GDP). Several high-risk subgroups had highly favorable ICERs < $12,554 (80,976 RMB) per QALY (1x GDP).For both in-trial and over a lifetime, it appears that enalapril-folic acid is a clinically and economically attractive medication compared with enalapril alone. Adding folic acid to enalapril may be a cost-effective strategy for the prevention of primary stroke in hypertensive patients from the Chinese health system perspective.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
almost发布了新的文献求助10
2秒前
烟花的应助被yts8885采纳,获得10
3秒前
3秒前
4秒前
4秒前
4秒前
4秒前
4秒前
5秒前
zhang发布了新的文献求助10
5秒前
6秒前
flyboy发布了新的文献求助10
6秒前
化学小猪发布了新的文献求助10
6秒前
6秒前
yts8885发布了新的文献求助10
6秒前
春风暮雪发布了新的文献求助10
7秒前
自由沂完成签到 ,获得积分10
9秒前
yts8885发布了新的文献求助10
10秒前
gchycc完成签到 ,获得积分10
10秒前
yts8885发布了新的文献求助10
10秒前
yts8885发布了新的文献求助10
10秒前
yts8885发布了新的文献求助10
10秒前
yts8885发布了新的文献求助10
10秒前
秋风的应助被852采纳,获得10
10秒前
10秒前
11秒前
赘婿的应助被dxftx采纳,获得10
11秒前
超级小蝴蝶完成签到 ,获得积分10
12秒前
hahahhah完成签到,获得积分10
13秒前
科研通AI6.3的应助被热爱学习采纳,获得30
13秒前
蛋儿完成签到 ,获得积分10
14秒前
16秒前
17秒前
wanci的应助被Nanowanie采纳,获得10
17秒前
wxyaaa完成签到,获得积分20
17秒前
18秒前
18秒前
文静的海发布了新的文献求助10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184686
求助须知:如何正确求助?哪些是违规求助? 9573640
关于积分的说明 21832630
捐赠科研通 7782020
什么是DOI,文献DOI怎么找? 3434404
关于科研通互助平台的介绍 2558513
邀请新用户注册赠送积分活动 2481010